chac1 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to CHAC1 Antibody

CHAC1 antibodies are immunological reagents specifically designed to detect and bind to the CHAC1 protein, a member of the gamma-glutamylcyclotransferase family. These antibodies have become increasingly important in research settings as CHAC1 has been implicated in various cellular processes and pathological conditions, including endoplasmic reticulum stress responses, glutathione metabolism, and cancer progression. CHAC1 antibodies are commercially available in multiple formats from various manufacturers, each optimized for specific experimental applications and research needs .

The significance of CHAC1 antibodies lies in their ability to reliably detect CHAC1 protein expression across different experimental conditions, enabling researchers to investigate the role of this protein in normal cellular function and in disease states. As research tools, these antibodies have contributed significantly to our understanding of CHAC1's biological functions and its involvement in various pathological processes.

Structure and Function of CHAC1 Protein

Understanding the structure and function of the CHAC1 protein is essential for appreciating the utility and applications of CHAC1 antibodies. CHAC1 is a 24 kDa protein (though often observed at approximately 38 kDa in experimental settings) that functions as a glutathione-specific gamma-glutamylcyclotransferase .

Enzymatic Activity and Cellular Functions

CHAC1 catalyzes the cleavage of glutathione into 5-oxo-L-proline and a Cys-Gly dipeptide, acting specifically on glutathione but not on other gamma-glutamyl peptides . This glutathione-degrading activity is significant because glutathione is the major intracellular antioxidant, making CHAC1 an important regulator of cellular redox balance and oxidative stress responses . The depletion of glutathione is also an important factor in apoptosis initiation and execution, connecting CHAC1 to cell death pathways .

Pathways and Regulation

CHAC1 functions as a pro-apoptotic component of the unfolded protein response pathway, mediating the pro-apoptotic effects of the ATF4-ATF3-DDIT3/CHOP cascade . The regulation of CHAC1 expression involves several transcription factors, including ATF4, ATF3, and CCAAT/enhancer-binding protein β (CEBPβ), which bind to specific elements in the CHAC1 promoter region . Recent research has also identified E2F Transcription Factor 1 as a potent activator of CHAC1 transcription in lung adenocarcinoma cells .

Beyond its role in stress responses, CHAC1 acts as a negative regulator of the Notch signaling pathway involved in embryonic neurogenesis. It inhibits Notch cleavage by furin, maintaining Notch in an immature inactive form, thereby promoting neurogenesis in embryos .

Types of CHAC1 Antibodies

CHAC1 antibodies are available in various formats, each with distinct characteristics suitable for different experimental applications. The main types of CHAC1 antibodies can be categorized based on their clonality, host species, and targeted epitopes.

Monoclonal versus Polyclonal CHAC1 Antibodies

Commercially available CHAC1 antibodies include both monoclonal and polyclonal variants:

  • Monoclonal CHAC1 antibodies: These antibodies are derived from a single B-cell clone, resulting in antibodies that recognize a single epitope on the CHAC1 protein. Examples include the mouse monoclonal CHAC1 antibody clone OTI1E2, which is suitable for immunohistochemistry on paraffin-embedded tissues (IHC-P) and reacts with human samples .

  • Polyclonal CHAC1 antibodies: These antibodies are derived from multiple B-cell lineages and recognize multiple epitopes on the CHAC1 protein. Examples include rabbit polyclonal antibodies that are suitable for Western blot (WB), immunohistochemistry (IHC), immunofluorescence (IF), and other applications, with reactivity against human, mouse, rat, and other species .

Host Species and Target Specificity

The majority of commercially available CHAC1 antibodies are rabbit-derived, though mouse monoclonal options are also available . These antibodies target various regions of the CHAC1 protein, including:

  • C-terminal region antibodies (e.g., ABIN2773808)

  • Internal region antibodies

  • N-terminal region antibodies (e.g., GTX120775)

  • Full-length protein antibodies (e.g., MA5-26311)

Applications of CHAC1 Antibodies

CHAC1 antibodies have been utilized in various experimental applications to investigate the expression, localization, and function of CHAC1 protein in different biological contexts.

Western Blotting

Western blotting (WB) is one of the most common applications for CHAC1 antibodies, allowing researchers to detect and quantify CHAC1 protein expression in cell and tissue lysates. Most commercial CHAC1 antibodies are validated for WB applications, with recommended dilutions typically ranging from 1:500 to 1:2000 . In WB applications, CHAC1 is typically observed as a band at approximately 38 kDa, despite its calculated molecular weight of 24 kDa .

Immunohistochemistry

Immunohistochemistry (IHC) applications of CHAC1 antibodies enable the visualization of CHAC1 protein expression in tissue sections, providing valuable insights into its localization and expression patterns in various physiological and pathological conditions. Several commercial CHAC1 antibodies are validated for IHC applications, with recommended dilutions ranging from 1:50 to 1:500 .

IHC studies using CHAC1 antibodies have revealed important findings, such as the overexpression of CHAC1 in Helicobacter pylori-infected parietal cells in the gastric mucosa . In these studies, CHAC1 antibodies helped identify varying degrees of CHAC1 expression in fundic-gland areas of gastric mucosa, with stronger expression observed in H. pylori-infected tissues .

Immunofluorescence

Immunofluorescence (IF) applications of CHAC1 antibodies allow for the detailed visualization of CHAC1 protein localization within cells. Several commercial CHAC1 antibodies are validated for IF applications . For example, immunofluorescent analysis of CHAC1 in COS7 cells transfected with a plasmid overexpressing CHAC1 has been performed using CHAC1 monoclonal antibodies .

Other Applications

CHAC1 antibodies have also been utilized in other experimental techniques, including:

  • Immunoprecipitation (IP) and co-immunoprecipitation (CoIP) to study protein-protein interactions involving CHAC1

  • Enzyme-linked immunosorbent assay (ELISA) for quantitative detection of CHAC1 protein

  • Chromatin immunoprecipitation (ChIP) assays to investigate transcription factor binding to the CHAC1 promoter region

These diverse applications highlight the versatility of CHAC1 antibodies as research tools for investigating various aspects of CHAC1 biology and function.

Research Findings and Clinical Significance

Research utilizing CHAC1 antibodies has contributed significantly to our understanding of CHAC1's biological functions and its implications in various disease states.

CHAC1 in Helicobacter pylori Infection

Studies employing CHAC1 antibodies have revealed that CHAC1 is overexpressed in Helicobacter pylori-infected gastric parietal cells. Immunohistochemistry with anti-CHAC1 monoclonal antibodies showed varying levels of CHAC1 expression in gastric mucosa, with strong expression specifically observed in H. pylori-infected parietal cells . This finding suggests a potential role for CHAC1 in the pathophysiology of H. pylori infection and related gastric disorders.

CHAC1 in Cancer Biology

Recent research has implicated CHAC1 in the progression of lung adenocarcinoma (LUAD). Studies found that CHAC1 expression was markedly higher in LUAD tissues compared to non-tumor tissues and positively correlated with poor prognosis. Mechanistically, CHAC1 was shown to act as a bridge connecting UBA2 and PKM2, enhancing the SUMOylation of PKM2 and subsequently activating the expression of glycolysis-related genes, promoting the Warburg effect in cancer cells . These findings suggest that CHAC1 could be a potential target for cancer therapy, and CHAC1 antibodies may have utility in cancer research and potentially in diagnostic applications.

CHAC1 in Stress Response Pathways

CHAC1 antibodies have been instrumental in elucidating the role of CHAC1 in cellular stress response pathways. Research has shown that CHAC1 is a downstream target of the ATF4-ATF3-DDIT3/CHOP cascade in the endoplasmic reticulum stress pathway. Chromatin immunoprecipitation (ChIP) studies using antibodies against ATF4, ATF3, and CEBPβ have confirmed the binding of these transcription factors to the CHAC1 promoter region in response to ER stress . These findings highlight the importance of CHAC1 in mediating cellular responses to stress conditions.

CHAC1 in Glutathione Metabolism

Studies utilizing CHAC1 antibodies have confirmed CHAC1's role in glutathione metabolism. Overexpression of CHAC1 in HEK293 cells led to robust depletion of glutathione, which was alleviated in a CHAC1 catalytic mutant . This finding underscores CHAC1's function as a glutathione-degrading enzyme and its potential impact on cellular redox balance and oxidative stress responses.

Technical Considerations for CHAC1 Antibody Usage

When working with CHAC1 antibodies, several technical considerations should be taken into account to ensure optimal experimental results.

Antibody Dilution and Optimization

The optimal dilution for CHAC1 antibodies varies depending on the specific antibody and application. For Western blot applications, recommended dilutions typically range from 1:500 to 1:2000 . For immunohistochemistry, recommended dilutions range from 1:50 to 1:500 . It is advisable to perform optimization experiments to determine the optimal antibody concentration for specific experimental conditions.

Sample Preparation and Compatibility

For Western blot applications, CHAC1 antibodies have been successfully used with various sample types, including cell lysates from HeLa, A549, CHO, U-251, C6, and RAW 264.7 cells, as well as tissue lysates from mouse brain and kidney . For immunohistochemistry, CHAC1 antibodies have been validated on formalin-fixed, paraffin-embedded human stomach tissue and rat brain tissue .

Controls and Validation

When using CHAC1 antibodies, it is advisable to include appropriate positive and negative controls to validate antibody specificity and performance. For example, CHAC1-overexpressing cells can serve as positive controls, as demonstrated in immunofluorescence studies with COS7 cells transfected with a CHAC1-overexpressing plasmid .

Future Perspectives and Research Directions

The development and application of CHAC1 antibodies continue to advance our understanding of CHAC1 biology and its implications in various physiological and pathological processes.

Emerging Roles of CHAC1 in Disease

Recent research has uncovered new roles for CHAC1 in various disease states, including cancer, infectious diseases, and stress-related disorders. CHAC1 antibodies will continue to be essential tools for investigating these emerging roles and elucidating the underlying mechanisms. The finding that CHAC1 blockade suppresses the progression of lung adenocarcinoma suggests potential therapeutic applications targeting CHAC1 , which may involve the development of new antibody-based approaches.

Development of Novel CHAC1 Antibodies

As research on CHAC1 continues to expand, there is a growing need for more specific and versatile CHAC1 antibodies. Future developments may include the production of antibodies targeting specific CHAC1 modifications or conformational states, as well as the development of antibodies optimized for emerging experimental techniques. The generation of antibodies against specific CHAC1 functional domains may also provide valuable tools for dissecting CHAC1's various biological activities.

Potential Diagnostic and Therapeutic Applications

Given CHAC1's involvement in various disease processes, CHAC1 antibodies may have potential diagnostic and therapeutic applications. In cancer diagnostics, CHAC1 antibodies could potentially serve as biomarkers for certain cancer types, such as lung adenocarcinoma, where CHAC1 overexpression correlates with poor prognosis . In therapeutic contexts, antibody-based approaches targeting CHAC1 could potentially modulate its activity in disease states characterized by dysregulated CHAC1 expression or function.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
chac1Glutathione-specific gamma-glutamylcyclotransferase 1 antibody; Gamma-GCG 1 antibody; EC 4.3.2.7 antibody; Cation transport regulator-like protein 1 antibody
Target Names
chac1
Uniprot No.

Target Background

Function
This antibody targets CHAC1, an enzyme that catalyzes the cleavage of glutathione into 5-oxo-L-proline and a Cys-Gly dipeptide. CHAC1 exhibits specificity for glutathione, not reacting with other gamma-glutamyl peptides. Depletion of glutathione plays a crucial role in the initiation and execution of apoptosis. CHAC1 acts as a pro-apoptotic component within the unfolded protein response pathway, mediating the pro-apoptotic effects of the ATF4-ATF3-DDIT3/CHOP cascade. Additionally, CHAC1 functions as a negative regulator of the Notch signaling pathway involved in embryonic neurogenesis. This regulation is achieved by inhibiting Notch cleavage through furin, maintaining Notch in an immature, inactive state, thereby promoting neurogenesis in embryos.
Database Links
Protein Families
Gamma-glutamylcyclotransferase family, ChaC subfamily
Subcellular Location
Cytoplasm, cytosol. Golgi apparatus, trans-Golgi network.

Q&A

What is CHAC1 and why is it important in research?

CHAC1 belongs to the chaC family and functions as an enzyme that degrades glutathione. While its complete function remains under investigation, CHAC1 has been identified as a component of the integrated stress response pathway. Research indicates CHAC1 is induced in Helicobacter pylori-infected gastric parietal cells, suggesting its potential role in cellular responses to pathogenic infection . CHAC1 is also implicated in the endoplasmic reticulum (ER) stress response pathway, making it a target of interest for researchers studying cellular stress mechanisms. To effectively study this protein, researchers typically employ anti-CHAC1 antibodies to detect expression patterns across different tissue types and under various experimental conditions.

What types of CHAC1 antibodies are available for research applications?

Various CHAC1 antibodies are available with different specificities and applications. Based on current research resources, these include:

  • Polyclonal antibodies targeting the C-terminal region of human CHAC1

  • Antibodies with reactivity to specific amino acid sequences (e.g., AA 43-264, AA 131-222, AA 188-237)

  • Monoclonal antibodies such as CHAC1-mAb (v1v2) used in immunohistochemistry applications

  • Conjugated antibodies with tags like HRP, biotin, FITC, and fluorophores for specialized applications

When selecting an antibody, researchers should consider the specific epitope recognition, host species, clonality, and verified applications to ensure compatibility with their experimental design.

How do I determine the optimal working dilution for CHAC1 antibodies?

Determining the optimal working dilution for CHAC1 antibodies is critically important for experimental success. The appropriate dilution should be determined empirically for each specific application and experimental system . Begin with the manufacturer's recommended range (typically 1:500 to 1:2000 for Western blotting) and perform a dilution series experiment.

For immunohistochemistry applications:

  • Prepare serial dilutions of the antibody (e.g., 1:100, 1:500, 1:1000, 1:2000)

  • Apply each dilution to identical tissue sections

  • Process all sections simultaneously using standard protocols

  • Evaluate signal-to-noise ratio at each dilution

  • Select the dilution that provides specific staining with minimal background

For Western blotting, a similar approach should be taken, testing multiple dilutions against the same protein amount. Remember that different lots of the same antibody may require adjusted dilutions, making this optimization process essential for each new antibody lot.

What are the recommended storage conditions for CHAC1 antibodies?

To maintain CHAC1 antibody integrity and functionality, appropriate storage is essential. According to research protocols, CHAC1 antibodies should be stored at -20°C for long-term preservation . For short-term use (up to one week), storage at 2-8°C is acceptable. To prevent protein degradation and activity loss:

  • Divide the antibody into small aliquots upon receipt to minimize freeze-thaw cycles

  • Store in recommended buffer conditions (typically PBS with sodium azide and stabilizers)

  • Avoid repeated freeze-thaw cycles which significantly reduce antibody activity

  • Follow manufacturer's specific recommendations for each formulation

  • Document storage conditions and dates when tracking experimental reproducibility

Proper storage significantly impacts experimental reproducibility, especially when working with sensitive applications like immunohistochemistry or immunofluorescence.

What are the validated applications for CHAC1 antibodies in research?

CHAC1 antibodies have been validated for several experimental applications, with specific methodological considerations for each:

Western Blotting (WB): CHAC1 antibodies have been validated for detecting the approximately 24 kDa CHAC1 protein . For optimal results:

  • Use appropriate positive controls (tissues with known CHAC1 expression)

  • Include reducing agents in sample preparation

  • Transfer proteins to PVDF or nitrocellulose membranes

  • Block with 5% skim milk in TBS-T

  • Incubate with primary antibody overnight at 4°C with shaking

Immunohistochemistry (IHC): For CHAC1 detection in tissue sections:

  • Perform antigen retrieval using citrate buffer (pH 6.0) for 20 minutes

  • Block endogenous peroxidase activity with 3% hydrogen peroxide

  • Use normal horse serum for blocking non-specific binding

  • Incubate with appropriately diluted primary antibody

  • Develop using enzyme-conjugated secondary antibodies and appropriate substrates

Immunofluorescence (IF): For cellular localization studies:

  • Fix cells appropriately (4% paraformaldehyde)

  • Permeabilize with 0.1% Triton X-100

  • Block with serum-based blocking buffer

  • Incubate with primary antibody at optimal dilution

  • Detect using fluorophore-conjugated secondary antibodies

How can I validate CHAC1 antibody specificity for my experimental system?

Validating antibody specificity is crucial for reliable research outcomes. A comprehensive validation approach includes:

  • Positive and negative controls: Use tissues or cells with known CHAC1 expression levels as positive controls (e.g., stress-induced cells) and those with minimal expression as negative controls

  • Peptide competition assay: Pre-incubate the antibody with the immunizing peptide before application; specific binding should be blocked

  • Multiple antibody approach: Compare results using antibodies targeting different epitopes of CHAC1

  • Genetic validation: Use CHAC1 knockout/knockdown models or overexpression systems to confirm specificity

  • Western blot analysis: Confirm the antibody detects a single band of expected molecular weight (approximately 24 kDa for CHAC1)

  • Cross-reactivity assessment: Test against known homologous proteins or across species when working with non-human models

For advanced validation, consider using active site mutants of CHAC1 (e.g., glutamate to glutamine mutations) to confirm specificity for the functional protein versus non-functional variants .

What protocol should I follow for Western blotting with CHAC1 antibodies?

For optimal Western blotting results with CHAC1 antibodies, follow this detailed protocol:

  • Sample preparation:

    • Lyse cells in RIPA buffer with protease inhibitors

    • Quantify protein concentration (Bradford or BCA assay)

    • Mix samples with Laemmli buffer containing β-mercaptoethanol

    • Heat at 95°C for 5 minutes

  • Gel electrophoresis and transfer:

    • Load 20-40 μg protein per lane on 12-15% SDS-PAGE gels (optimal for 24 kDa CHAC1)

    • Run at 100-120V until adequate separation

    • Transfer to PVDF membrane at 100V for 1 hour (wet transfer)

  • Antibody incubation:

    • Block with 5% skim milk in TBS-T for 1 hour at room temperature

    • Incubate with primary CHAC1 antibody (at predetermined optimal dilution) overnight at 4°C with shaking

    • Wash 3-5 times with TBS-T (5 minutes each)

    • Incubate with HRP-conjugated secondary antibody for 1 hour at room temperature

    • Wash 3-5 times with TBS-T (5 minutes each)

  • Detection:

    • Apply ECL substrate

    • Image using appropriate detection system

    • Expected molecular weight for CHAC1: 24 kDa

For enhanced sensitivity when detecting low CHAC1 expression, consider signal amplification systems or more sensitive detection reagents.

How can I design experiments to study CHAC1 expression in response to cellular stress?

CHAC1 is induced as part of the integrated stress response rather than exclusively during ER stress . To effectively study CHAC1 expression dynamics:

  • Stress induction models:

    • ER stress: Treat cells with tunicamycin (1-5 μg/ml) or thapsigargin (1-3 μM) for 4-24 hours

    • Amino acid starvation: Use histidinol treatment

    • Pathogen-induced stress: H. pylori infection models

  • Time-course experiments:

    • Collect samples at multiple time points (0, 2, 4, 8, 12, 24 hours)

    • Analyze CHAC1 protein expression by Western blotting

    • Compare with known ER stress markers (BiP, CHOP)

  • Quantification approaches:

    • For protein: Western blot with densitometry analysis

    • For mRNA: Real-time RT-PCR with appropriate normalization

      • When studying specific cell types (e.g., parietal cells), normalize to cell-specific markers like proton pump/H,K-ATPase α subunit

  • Promoter activity analysis:

    • Use CHAC1 promoter-luciferase reporter constructs

    • The region between -267 to +133 relative to transcription start is critical for basal and stress-induced transcription

    • Assess activation under different stress conditions

What immunohistochemistry techniques are most effective for detecting CHAC1 in tissue samples?

For optimal CHAC1 detection in tissue samples, implement these specialized IHC techniques:

  • Tissue preparation:

    • For FFPE samples: 4% formalin fixation for 24-48 hours followed by paraffin embedding

    • Section thickness: 4-5 μm for optimal antibody penetration

    • Mount on positively charged slides

  • Antigen retrieval (critical step):

    • Heat-induced epitope retrieval in 10 mM citrate buffer (pH 6.0) for 20 minutes via microwave

    • Allow gradual cooling to room temperature

  • Signal enhancement protocol:

    • Block endogenous peroxidase with 3% hydrogen peroxide in methanol for 10 minutes

    • Block non-specific binding with normal horse serum

    • Use high-sensitivity detection systems (e.g., Vectastain Universal Elite ABC Kit)

    • For weak signals, consider tyramide signal amplification

  • Dual-staining protocols for colocalization studies:

    • For CHAC1 with cell-type markers (e.g., H,K-ATPase for parietal cells)

    • Use alkaline phosphatase-conjugated secondary antibody with VECTOR Blue Alkaline Phosphatase Substrate Kit III

    • Alternatively, use fluorescein isothiocyanate-conjugated streptavidin

    • Between staining rounds, inactivate previous antibodies by microwaving in citrate buffer

  • Controls and interpretation:

    • Include tissue with known CHAC1 expression patterns (e.g., H. pylori-infected gastric mucosa)

    • Interpret staining intensity on a scale: weak (few to many cells) to strong expression

How can I use ChIP assays to study transcription factor binding to the CHAC1 promoter?

Chromatin immunoprecipitation (ChIP) is valuable for studying transcriptional regulation of CHAC1. Based on research findings that ATF/CRE elements direct CHAC1 transcription, follow this specialized protocol:

  • Cell preparation:

    • Culture HEK293 cells to 90% confluence

    • Induce stress with appropriate stimuli (e.g., 3 μM thapsigargin for 4 hours)

  • Crosslinking and chromatin shearing:

    • Resuspend cells in PBS with protease inhibitors

    • Add formaldehyde (1% final concentration) to cross-link chromatin

    • Quench after 10 minutes with glycine (0.125 M final concentration)

    • Shear chromatin with 10 bursts of 20 seconds each, with 4-minute cooling in ice-ethanol bath between bursts

  • Immunoprecipitation:

    • Incubate extracts with 2-5 μg/ml antibody against transcription factors of interest (ATF4, ATF3, or CEBPβ)

    • Capture chromatin-antibody complexes using protein A-agarose beads

    • Include "no antibody" samples as negative controls

  • DNA recovery and analysis:

    • Release DNA fragments by incubating with 0.2 M NaCl overnight at 65°C

    • Treat with Proteinase K (0.1 mg/ml)

    • Purify DNA using a QIAquick PCR purification kit

    • Analyze by qPCR using primers specific to CHAC1 promoter regions

  • Validation:

    • Use positive control regions known to be bound by your transcription factor of interest

    • Confirm specificity with regions known not to be bound (e.g., JMJD3 R1 vs. R5 regions)

    • Consider >2-fold enrichment as validation threshold

What are common issues with CHAC1 antibody experiments and how can they be resolved?

IssuePossible CausesSolutions
No signal in Western blotInsufficient protein loading; Antibody concentration too low; Protein degradationIncrease protein loading to 40-60 μg; Optimize antibody dilution; Use fresh samples with protease inhibitors
Multiple bands in Western blotNon-specific binding; Protein degradation; Cross-reactivityIncrease blocking stringency; Use freshly prepared samples; Try different antibody targeting another epitope
High background in IHCInsufficient blocking; Antibody concentration too high; Non-specific bindingIncrease blocking time; Optimize antibody dilution; Include additional blocking agents (e.g., BSA)
Variable staining intensity in IHCInconsistent antigen retrieval; Sample fixation differences; Endogenous peroxidase activityStandardize antigen retrieval protocol; Control fixation times; Ensure thorough peroxidase blocking
Poor reproducibility between experimentsAntibody lot variations; Storage conditions; Protocol inconsistenciesUse same antibody lot; Aliquot antibodies to avoid freeze-thaw cycles; Standardize protocols with detailed SOPs

How can I optimize CHAC1 detection in cells with low baseline expression?

Detecting CHAC1 in cells with low baseline expression requires specialized approaches:

  • Signal amplification strategies:

    • Use high-sensitivity detection systems (Super Signal West Femto or similar)

    • Consider biotin-streptavidin amplification systems

    • For IHC, implement tyramide signal amplification (TSA)

  • Enrichment approaches:

    • Concentrate protein samples using immunoprecipitation before Western blotting

    • For tissue sections, consider thicker sections (6-8 μm) to increase target protein amount

  • Stress induction:

    • Since CHAC1 is stress-responsive, consider mild stress induction before analysis

    • Tunicamycin, thapsigargin, or amino acid starvation can increase expression levels

  • Technical optimization:

    • Extend primary antibody incubation time (overnight at 4°C or longer)

    • Increase antibody concentration while controlling for background

    • Use highly sensitive digital imaging systems with extended exposure capabilities

  • Alternative detection methods:

    • Consider PCR-based methods for very low expression

    • Normalize CHAC1 expression to cell-type specific markers when appropriate

What controls should I include when studying CHAC1 in different experimental systems?

A comprehensive control strategy ensures reliable CHAC1 research findings:

  • Positive controls:

    • Cell lines with known CHAC1 expression (e.g., stressed HEK293 cells)

    • Tissues with documented expression patterns (e.g., H. pylori-infected gastric mucosa)

    • Recombinant CHAC1 protein for Western blot standardization

  • Negative controls:

    • Antibody diluent without primary antibody

    • Isotype control antibodies

    • Non-stressed cells with minimal CHAC1 expression

    • Pre-immune serum for polyclonal antibodies

  • Specificity controls:

    • Peptide competition/blocking studies

    • CHAC1 knockout/knockdown cells or tissues

    • CHAC1 mutants (e.g., active site E-to-Q mutation)

  • Processing controls:

    • Housekeeping proteins for Western blot loading (β-actin, GAPDH)

    • Known cell-type specific markers for normalization (e.g., H,K-ATPase for parietal cells)

    • Standard curve with recombinant protein for quantitative analyses

  • Cross-validation approach:

    • Confirm findings using multiple antibodies targeting different epitopes

    • Validate protein expression with corresponding mRNA levels

    • Use multiple detection techniques (WB, IHC, IF) for comprehensive verification

How is CHAC1 antibody being used to study Helicobacter pylori infection mechanisms?

CHAC1 antibodies have provided valuable insights into H. pylori infection mechanisms:

  • Cellular tropism studies:

    • CHAC1 antibodies have revealed that H. pylori specifically induces CHAC1 overexpression in gastric parietal cells that express the proton pump/H,K-ATPase α subunit

    • Double-enzyme or fluorescence IHC with combinations of anti-H. pylori, anti-proton pump, and anti-CHAC1 antibodies have demonstrated direct infection of parietal cells

  • Infection-induced molecular changes:

    • CHAC1 detection has helped characterize the specific stress response in infected cells

    • Immunoelectron microscopy using CHAC1 antibodies has revealed intact H. pylori in the secretory canaliculi of infected parietal cells

  • Quantitative analysis of infection impact:

    • By normalizing CHAC1 mRNA expression to proton pump expression, researchers identified significant CHAC1 overexpression in 35% of H. pylori-infected samples

    • This approach distinguishes infection-specific changes from background expression

  • Pathogenesis mechanisms:

    • Since CHAC1 degrades glutathione, its antibody-detected overexpression suggests a mechanism for oxidative stress induction during infection

    • Correlation of CHAC1 expression with cellular proliferation markers (Ki67) provides insights into infection-induced tissue remodeling

What methods can I use to study CHAC1 promoter regulation using antibody-based approaches?

Studying CHAC1 promoter regulation requires specialized antibody-based approaches:

  • ChIP-seq analysis:

    • Use antibodies against transcription factors (ATF4, ATF3, CEBPβ) to immunoprecipitate chromatin

    • Sequence bound DNA to identify genome-wide binding sites

    • Compare binding patterns under different stress conditions

  • Transcription factor binding analysis:

    • Combine ChIP with qPCR to quantify binding at specific CHAC1 promoter regions

    • Focus on the region between -267 to +133 relative to transcription start, which is critical for basal and stress-induced transcription

    • Assess binding enrichment under different stress conditions (ER stress, amino acid starvation)

  • Reporter assays with antibody validation:

    • Use CHAC1 promoter-luciferase constructs to assess activity

    • Combine with siRNA knockdown of transcription factors

    • Validate knockdown efficiency using antibodies against target transcription factors

  • Protein-DNA interaction mapping:

    • Perform DNA affinity precipitation assays using biotinylated CHAC1 promoter fragments

    • Identify bound proteins using specific antibodies

    • Confirm interactions using electrophoretic mobility shift assays (EMSA)

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.